The impact of sex hormones and metabolic markers on depressive symptoms and cognitive functioning in PCOS patients

References

• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–551.
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–861.
   PubMed Web of Science ®Google Scholar
• Baldauff NH, Witchel SF. Polycystic ovary syndrome in adolescent girls. Curr Opin Endocrinol Diabetes Obes. 2017;24:56–66.
   PubMed Web of Science ®Google Scholar
• Dewailly D. Diagnostic criteria for PCOS: is there a need for a rethink? Best Pract Res Clin Obstet Gynaecol. 2016;37:5–11.
   PubMed Web of Science ®Google Scholar
• Jedel E, Waern M, Gustafson D, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod. 2010;25:450–456.
   PubMed Web of Science ®Google Scholar
• Blay SL, Aguiar JV, Passos IC. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. NDT. 2016;12:2895–2903.
   Google Scholar
• Franik G, Krysta K, Madej P, et al. Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32:1014–1017.
   PubMed Web of Science ®Google Scholar
• Moran LJ, March WA, Whitrow MJ, et al. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum Reprod. 2015;30:466–472.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19:83.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32:1075–1091.
   PubMed Web of Science ®Google Scholar
• Barnard L, Balen AH, Ferriday D, et al. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007;32:906–914.
   PubMed Web of Science ®Google Scholar
• Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007;51:587–596.
   PubMed Web of Science ®Google Scholar
• Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav. 2007;51:579–586.
   PubMed Web of Science ®Google Scholar
• Barry JA, Parekh HS, Hardiman PJ. Visual-spatial cognition in women with polycystic ovarian syndrome: the role of androgens. Hum Reprod. 2013;28:2832–2837.
   PubMed Web of Science ®Google Scholar
• Lujan ME, Mergler RJ. Cognitive function in women with polycystic ovary syndrome (PCOS): impact of reproductive and metabolic factors. Fertil Steril. 2015;104:e129.
   Web of Science ®Google Scholar
• Soleman RS, Kreukels BPC, Veltman DJ, et al. Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory. Fertil Steril. 2016;105:1314–1321.e1311.
   PubMed Web of Science ®Google Scholar
• Rees DA, Udiawar M, Berlot R, et al. White matter microstructure and cognitive function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016;101:314–323.
   PubMed Web of Science ®Google Scholar
• Castellano CA, Baillargeon JP, Nugent S, et al. Regional brain glucose hypometabolism in young women with polycystic ovary syndrome: possible link to mild insulin resistance. PLoS One. 2015;10:e0144116.
   PubMed Web of Science ®Google Scholar
• Marsh CA, Berent-Spillson A, Love T, et al. Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study. Fertil Steril. 2013;100:200–207.e201.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-ii,1-253.
   Google Scholar
• Corrigan JD, Hinkeldey NS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol. 1987;43:402–409.
   PubMed Web of Science ®Google Scholar
• Jensen AR, Rohwer WD, Jr. The Stroop color-word test: a review. Acta Psychol (Amst). 1966;25:36–93.
   PubMed Web of Science ®Google Scholar
• Crowe SF. Decrease in performance on the verbal fluency test as a function of time: evaluation in a young healthy sample. J Clin Exp Neuropsychol. 1998;20:391–401.
   PubMed Web of Science ®Google Scholar
• Parnowski T, Jernajczyk W. Beck's depression inventory in the rating of mood in normal subjects and in patients with affective disturbances. Psychiatr Pol. 1977;11:417–421.
   PubMedGoogle Scholar
• Spritzer PM. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. Arq Bras Endocrinol Metabol. 2014;58:182–187.
   PubMed Web of Science ®Google Scholar
• Vignesh JP, Mohan V. Polycystic ovary syndrome: a component of metabolic syndrome? J Postgrad Med. 2007;53:128–134.
   PubMed Web of Science ®Google Scholar
• Tan S, Hahn S, Janssen OE. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Panminerva Med. 2005;47:211–217.
   PubMed Web of Science ®Google Scholar
• Stapinska-Syniec A, Grabowska K, Szpotanska-Sikorska M, Pietrzak B. Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome. 2018;34:597–600.
   Google Scholar
• Carbillon L, Gronier H, Cedrin-Durnerin I, et al. The impact of ovulation induction and ovarian stimulation on the risk of pregnancy-induced hypertension and on neonatal outcomes: a case/control study. Eur J Obstet Gynecol Reprod Biol. 2017;217:137–143.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Kurdoglu Z, Yildiz S, et al. The relationship between atypical depression and insulin resistance in patients with polycystic ovary syndrome and major depression. Psychiatry Res. 2017;258:171–176.
   PubMed Web of Science ®Google Scholar
• Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011;26:3339–3345.
   PubMed Web of Science ®Google Scholar
• Klimczak D, Szlendak-Sauer K, Radowicki S. Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;184:43–47.
   PubMed Web of Science ®Google Scholar
• Sabayan B, Foroughinia F, Borhani Haghighi A, et al. Are women with polycystic ovary syndrome (PCOS) at higher risk for development of Alzheimer disease? Alzheimer Dis Assoc Disord. 2007;21:265.
   PubMed Web of Science ®Google Scholar
• Bourdel-Marchasson I, Lapre E, Laksir H, et al. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab. 2010;36:173–181.
   PubMed Web of Science ®Google Scholar
• Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26:1044–1080.
   PubMed Web of Science ®Google Scholar
• Cree-Green M, Rahat H, Newcomer BR, et al. Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome. J Endocr Soc. 2017;1:931–944.
   PubMed Web of Science ®Google Scholar
• Lewy VD, Danadian K, Witchel SF, et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr. 2001;138:38–44.
   PubMed Web of Science ®Google Scholar
• Mennenga SE, Koebele SV, Mousa AA, et al. Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats. Steroids. 2015;99:16–25.
   PubMed Web of Science ®Google Scholar
• Smith P, Steckler TL, Veiga-Lopez A, et al. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod. 2009;80:726–736.
   PubMed Web of Science ®Google Scholar
• Hidalgo-Lopez E, Pletzer B. Interactive effects of dopamine baseline levels and cycle phase on executive functions: the role of progesterone. Front Neurosci. 2017;11:403.
   PubMed Web of Science ®Google Scholar
• Wilkowska A, Rynkiewicz A, Wdowczyk J, et al. Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression. Cardiol J. 2017, in press.
   PubMedGoogle Scholar
• Stomby A, Boraxbekk CJ, Lundquist A, et al. Higher diurnal salivary cortisol levels are related to smaller prefrontal cortex surface area in elderly men and women. Eur J Endocrinol. 2016;175:117–126.
   PubMed Web of Science ®Google Scholar
• Peters M, Laeng B, Latham K, et al. A Redrawn Vandenberg and Kuse Mental Rotations Test – different versions and factors that affect performance. Brain Cogn. 1995;28:39–58.
   PubMed Web of Science ®Google Scholar
• Semrud-Clikeman M, Fine JG, Bledsoe J, et al. Gender differences in brain activation on a mental rotation task. Int J Neurosci. 2012;122:590–597.
   PubMed Web of Science ®Google Scholar
• Bors DA, Vigneau F. Sex differences on the mental rotation test: an analysis of item types. Learn Individ Differ. 2011;21:129–132.
   Web of Science ®Google Scholar
• Moè A. Are males always better than females in mental rotation? Exploring a gender belief explanation. Learn Individ Differ. 2009;19:21–27.
   Web of Science ®Google Scholar